Abbott TR, Dhamdhere G, Liu Y et al (2020) Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza. Cell 181:865-876.e12. https://doi.org/10.1016/j.cell.2020.04.020

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agostini HT, Ryschkewitsch CF, Singer EJ, Stoner GL (1997) JC virus regulatory region rearrangements and genotypes in progressive multifocal leukoencephalopathy: two independent aspects of virus variation. J Gen Virol 78:659–664. https://doi.org/10.1099/0022-1317-78-3-659

Article  CAS  PubMed  Google Scholar 

Akan I, Sariyer IK, Biffi R et al (2006) Human polyomavirus JCV late leader peptide region contains important regulatory elements. Virology 349:66–78. https://doi.org/10.1016/j.virol.2006.01.025

Article  CAS  PubMed  Google Scholar 

Anand P, Hotan GC, Vogel A et al (2019) Progressive multifocal leukoencephalopathy: a 25-year retrospective cohort study. Neurol Neuroimmunol Neuroinflamm 6:e618. https://doi.org/10.1212/NXI.0000000000000618

Astrom KE, Mancall EL, Richardson EP (1958) Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin’s disease. Brain 81:93–111. https://doi.org/10.1093/brain/81.1.93

Article  CAS  PubMed  Google Scholar 

Ault GS (1997) Activity of JC virus archetype and PML-type regulatory regions in glial cells. J Gen Virol 78(Pt 1):163–169. https://doi.org/10.1099/0022-1317-78-1-163

Article  CAS  PubMed  Google Scholar 

Ault GS, Stoner GL (1993) Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure. J Gen Virol 74(Pt 8):1499–1507. https://doi.org/10.1099/0022-1317-74-8-1499

Article  CAS  PubMed  Google Scholar 

Bakal JA, Charlton CL, Hlavay B et al (2021) Progressive multifocal leukoencephalopathy and Creutzfeldt-Jakob disease: population-wide incidences, comorbidities, costs of care, and outcomes. J Neurovirol 27:476–481. https://doi.org/10.1007/s13365-021-00983-z

Article  CAS  PubMed  Google Scholar 

Bao Z, Fang K, Miao Z et al (2021) Human cerebral organoid implantation alleviated the neurological deficits of traumatic brain injury in mice. Oxid Med Cell Longev 2021:6338722. https://doi.org/10.1155/2021/6338722

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barreras P, Pamies D, Monaco MC et al (2022) A human-derived 3D brain organoid model to study JC virus infection. J Neurovirol 28:17–26. https://doi.org/10.1007/s13365-022-01062-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berger JR (2014) Chapter 17 - Progressive multifocal leukoencephalopathy. In: Tselis AC, Booss J (eds) Handbook of Clinical Neurology. Elsevier, pp 357–376

Google Scholar 

Berger JR, Aksamit AJ, Clifford DB et al (2013a) PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 80:1430–1438. https://doi.org/10.1212/WNL.0b013e31828c2fa1

Article  PubMed  PubMed Central  Google Scholar 

Berger JR, Hartung H-P (2023) Commentary: progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies. Front Neurol 14:1146027. https://doi.org/10.3389/fneur.2023.1146027

Article  PubMed  PubMed Central  Google Scholar 

Berger JR, Houff SA, Gurwell J et al (2013b) JC virus antibody status underestimates infection rates. Ann Neurol 74:84–90. https://doi.org/10.1002/ana.23893

Article  PubMed  PubMed Central  Google Scholar 

Berger JR, Koralnik IJ (2005) Progressive multifocal leukoencephalopathy and natalizumab–unforeseen consequences. N Engl J Med 353:414–416. https://doi.org/10.1056/NEJMe058122

Article  CAS  PubMed  Google Scholar 

Bofill-Mas S, Clemente-Casares P, Major EO et al (2003) Analysis of the excreted JC virus strains and their potential oral transmission. J Neurovirol 9:498–507. https://doi.org/10.1080/13550280390218887

Article  CAS  PubMed  Google Scholar 

Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P et al (2001) Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol 75:10290–10299. https://doi.org/10.1128/JVI.75.21.10290-10299.2001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bofill-Mas S, Girones R (2003) Role of the environment in the transmission of JC virus. J Neurovirol 9:54–58. https://doi.org/10.1080/13550280390195306

Article  CAS  PubMed  Google Scholar 

Bollag B, Hofstetter CA, Reviriego-Mendoza MM, Frisque RJ (2010) JC virus small T antigen binds phosphatase PP2A and Rb family proteins and is required for efficient viral DNA replication activity. PLoS One 5:e10606. https://doi.org/10.1371/journal.pone.0010606

Brambilla AM, Castagna A, Novati R et al (1999) Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy. J Neurol 246:723–725. https://doi.org/10.1007/s004150050440

Article  CAS  PubMed  Google Scholar 

Brickelmaier M, Lugovskoy A, Kartikeyan R et al (2009) Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 53:1840–1849. https://doi.org/10.1128/AAC.01614-08

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chapagain ML, Sumibcay L, Gurjav U et al (2008) Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells. J Neurovirol 14:448–454. https://doi.org/10.1080/13550280802235916

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen NN, Kerr D, Chang CF et al (1997) Evidence for regulation of transcription and replication of the human neurotropic virus JCV genome by the human S(mu)bp-2 protein in glial cells. Gene 185:55–62. https://doi.org/10.1016/s0378-1119(96)00630-0

Article  CAS  PubMed  Google Scholar 

Cheng Y, Ma N, Witt C et al (2021) Face masks effectively limit the probability of SARS-CoV-2 transmission. Science 372:1439–1443. https://doi.org/10.1126/science.abg6296

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiang C, Dvorkin S, Chiang JJ et al (2021) The small t antigen of JC virus antagonizes RIG-I-mediated innate immunity by inhibiting TRIM25’s RNA binding ability. mBio 12:e00620–21. https://doi.org/10.1128/mBio.00620-21

Christensen KLY, Holman RC, Hammett TA et al (2010) Progressive multifocal leukoencephalopathy deaths in the USA, 1979–2005. Neuroepidemiology 35:178–184. https://doi.org/10.1159/000311014

Article  PubMed  Google Scholar 

Cortese I, Muranski P, Enose-Akahata Y et al (2019) Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med 380:1597–1605. https://doi.org/10.1056/NEJMoa1815039

Article  CAS  PubMed  Google Scholar 

Cortese I, Reich DS, Nath A (2021) Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol 17:37–51. https://doi.org/10.1038/s41582-020-00427-y

Article  PubMed  Google Scholar 

Dang X, Axthelm MK, Letvin NL, Koralnik IJ (2005) Rearrangement of simian virus 40 regulatory region is not required for induction of progressive multifocal leukoencephalopathy in immunosuppressed rhesus monkeys. J Virol 79:1361–1366. https://doi.org/10.1128/JVI.79.3.1361-1366.2005

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daniel AM, Swenson JJ, Mayreddy RP et al (1996) Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity. Virology 216:90–101. https://doi.org/10.1006/viro.1996.0037

Article  CAS  PubMed  Google Scholar 

Daniel DC, Wortman MJ, Schiller RJ et al (2001) Coordinate effects of human immunodeficiency virus type 1 protein Tat and cellular protein Puralpha on DNA replication initiated at the JC virus origin. J Gen Virol 82:1543–1553. https://doi.org/10.1099/0022-1317-82-7-1543

Article  CAS  PubMed  Google Scholar 

Daniels R, Rusan NM, Wadsworth P, Hebert DN (2006) SV40 VP2 and VP3 insertion into ER membranes is controlled by the capsid protein VP1: implications for DNA translocation out of the ER. Mol Cell 24:955–966. https://doi.org/10.1016/j.molcel.2006.11.001

Article  CAS  PubMed  Google Scholar 

d’Arminio Monforte A, Cinque P, Vago L et al (1997) A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients. J Neurol 244:35–39. https://doi.org/10.1007/pl00007727

Article  PubMed  Google Scholar 

Dash PK, Kaminski R, Bella R et al (2019) Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice. Nat Commun 10:2753. https://doi.org/10.1038/s41467-019-10366-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Datta PK, Kaminski R, Hu W et al (2016) HIV-1 latency and eradication: past, present and future. Curr HIV Res 14:431–441. https://doi.org/10.2174/1570162x14666160324125536

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Luca A, Ammassari A, Pezzotti P et al (2008) Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leu